Current Pain and Headache Reports

, Volume 13, Issue 3, pp 227–230 | Cite as

Reducing the cost of headache medication



Although medication costs make up one of the smallest portions of the overall expense of headache care, it is the segment of expense that often impacts the patient most directly. The advent of triptans marked a major advance in migraine therapy, but their high cost has limited their widespread use. Four options can be considered as potential means to reduce the cost of triptans. These include compulsory licensing, exclusive contracting, over-the-counter availability, and the introduction of generic triptans. Each method impacts the consumer, third-party payer, or pharmaceutical company in a different manner.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Steinbrook R: Closing the affordability gap for drugs in low-income countries. N Engl J Med 2007, 357:1996–1999.PubMedCrossRefGoogle Scholar
  2. 2.
    World Health Organization: WHO model list of essential medicines: 15th list. Available at Accessed February 2008.
  3. 3.
    Department of Defense Pharmacoeconomic Center: Guidance for the new oral 5-HT receptor agonist (triptan) contract. Available at Accessed December 2007.
  4. 4.
    Tfelt-Hansen P, Steiner TJ: Over-the-counter triptans for migraine. What are the implications? CNS Drugs 2007, 21:877–883.PubMedCrossRefGoogle Scholar
  5. 5.
    On the Pharm: Sumatriptan approved for OTC use in the UK. Available at Accessed January 2008.
  6. 6.
    Frank RG: The ongoing regulation of generic drugs. N Engl J Med 2007, 357:1993–1996.PubMedCrossRefGoogle Scholar
  7. 7.
    Migraenikerforbundet; The Danish Migraine Association: The price of sumatriptan reaches an all time low. Available at Accessed November 2008.

Copyright information

© Current Medicine Group, LLC 2009

Authors and Affiliations

  1. 1.Department of Medicine, Boonshoft School of MedicineWright State UniversityDaytonUSA

Personalised recommendations